FOXO acquires Vector BioSource for $500K cash, Series E shares, and warrants

FOXO TECHNOLOGIES INC.

Purchase price includes $500K cash, 60,000 Series E Preferred shares, and warrants for up to $2M common stock at 110% of pre-close price.
Contingent earnout of up to 80,000 Series E shares if Vector achieves $4M qualifying revenue in year 2 after closing.
Closing requires due diligence, final warrants/employment agreements, and 12-month budget with up to $1.2M funding.
Sellers have limited right to repurchase shares at fair market value with a floor.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.